For this purpose, two highly metastasis-specific melanoma cancer cell lines were selected: one is A375 which is BRAF mutated and activating mutations of the protooncogene BRAF have been observed in approximately 50% of malignant melanomas. The gene discussed is BRAF; the disease is melanoma.